Bio-Technology General
BG
BI
Bio-Technology General
About
BTG invests heavily in the process of creating new medicines through its research and development centers and through research collaboration with scientific institutes and biotechnology and pharmaceutical companies throughout the world.
Key facts
- Type
- Company
- Headquarters
- Israel
- Portfolio companies
- 1
- Stages
- Series B
- Cheque size
- $16M to $16M
- Sector focus
- Life Sciences
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 30 Sept 2001 | Gamida Cell | Series B | $16M |
Write the first review
Frequently asked
What companies has Bio-Technology General invested in?
Bio-Technology General has invested in Gamida Cell.
SEC filings, insider activity, nonprofit links and pay benchmarks for Bio-Technology General:
